With the acquisition of the company, which also operates in Turkey, UPS will increase its end-to-end global healthcare logistics capabilities and expand its scale of operations and expertise in Europe and Latin America.
PS Healthcare (NYSE: UPS) announced plans to acquire Bomi Group, the industry-leading international healthcare logistics provider. As a result of this step, temperature-controlled facilities in 14 countries including Turkey and approximately 3.000 highly skilled Bomi Group team members in Europe and Latin America will be added to the UPS Healthcare network.
Kate Gutmann, Vice President and President, Healthcare and Supply Chain Solutions, UPS International, said, “As a leading global healthcare logistics company, Bomi is expanding our portfolio of services and accelerating our journey to become a leader in complex healthcare logistics. UPS Healthcare and Bomi Group employees share similar values, and our corporate cultures are based on an attitude that never compromises on quality. “Combining these two teams will significantly enhance our healthcare customers' ability to thrive and deliver life-saving innovations.”
Bomi Group, a quality-oriented company dedicated to healthcare and establishing long-term business relationships with more than 150 customers around the world, has been providing customized high value-added services to the medical technology and pharmaceutical industries since 1985.
Important leaders of Bomi Group, such as company CEO Marco Ruini, will remain in their posts, ensuring that the service provided to Bomi Group customers continues smoothly after the sale. Bomi Group employees will also continue to play an important role in the merged organization.
Marco Ruini, CEO of Bomi Group, said: “With over 35 years in the healthcare logistics industry, our team has succeeded in developing best-in-class services designed to meet and exceed the needs of our medical technology and pharmaceutical customers. “Joining the UPS team will grow these capabilities and create a more integrated and intelligent global network for our customers.”
The acquisition will add more than 350 temperature-controlled vehicles and a total 391 thousand square foot operations center to UPS Healthcare's global footprint. Thus, customers will have access to faster shipping times, greater production flexibility and a platform to help them attract new business contacts. The acquisition of the company will play an important role in the delivery of a new generation of pharmaceutical and biological therapies, which increasingly need time- and temperature-sensitive logistics.
“We are focused on building the capabilities and services that enable our customers to deliver the latest healthcare innovations,” said Wes Wheeler, President of UPS Healthcare. We have great respect for the knowledge and expertise of the Bomi team. We are excited to combine Bomi's talent, expertise and skills with UPS Healthcare. Together, we will provide our customers with unique solutions powered by UPS's integrated, global intelligent logistics network.”
The acquisition of Bomi is part of UPS Healthcare's effort to expand its network and services to meet growing demand. The latest expansion steps include newly built and soon-to-open state-of-the-art healthcare logistics facilities in Germany and Australia, and expanded centers in Hungary and the Netherlands.
In addition, UPS Healthcare has recently developed UPS Premier, a technology-based service that can prioritize and track critical shipments within the UPS global network within 3 meters of their location. UPS Premier provides UPS Healthcare customers with world-class visibility, inspection, reliability and product recovery capabilities.
These expansions and new services help UPS Healthcare customers turn logistics into a competitive advantage by meeting their complex needs.
The acquisition process is expected to be completed by the end of the year. JP Morgan Securities LLC is acting as UPS' financial advisor in the acquisition, the value and terms of which have not yet been disclosed.
Be the first to comment